October 2025, Las Vegas – Top NAD+ Manufacturer Unveils UTHEVER® NMN, UthPeak® NMNH, & LipoAvail® Liposomal Tech to Capture NAD+ Supplement Boom

EffePharm Takes Center Stage at SupplySide Global 2025 The global nutraceutical industry is abuzz as SupplySide Global 2025 prepares to kick off in Las Vegas this October 29-30, and EffePharm is set to steal the spotlight. As a trailblazer in NAD+ manufacturing, bulk NMN supply, and liposomal delivery technology, EffePharm is gearing up to showcase game-changing innovations that promise to redefine anti-aging and wellness at Booth #4555. For brands ready to capitalize on the $60 billion global anti-aging market, this is your opportunity to connect with a partner that combines clinical rigor, global regulatory expertise, and cutting-edge manufacturing capabilities. Let’s dive into what makes EffePharm the must-see exhibitor of the year. NAD+ Revolution: UTHEVER® NMN & UthPeak® NMNH, Science, Compliance, and Market Domination NAD+ (Nicotinamide Adenine Dinucleotide) isn’t just a buzzword; it’s the cellular “fuel” that powers energy production and DNA repair, and its decline with age is linked to everything from fatigue to age-related decline. EffePharm is doubling down on this critical pathway with two flagship innovations designed to meet post-FDA approval demand and set new standards for efficacy. UTHEVER® NMN: The Gold Standard in Bulk NMN, Now FDA-Approved The U.S. NAD+ market just got a seismic jolt: After…

EffePharm Debuts in Thailand, Spotlighting Clinical-Proven Anti-Aging Solutions Bangkok took center stage in September 2025 as the host of Vitafoods Asia 2025, the region’s premier summit for health and nutrition innovation. Among the global exhibitors, EffePharm, a trailblazer in nad+ manufacturing, bulk NMN supply, and liposomal supplement technology, made its highly anticipated debut, zeroing in on a critical challenge: Asia-Pacific’s rapidly aging population. Showcasing its clinically validated NAD+ boosters (UTHEVER® NMN and UthPeak® NMNH, reduced NMN) and game-changing LipoAvail® liposomal delivery system, EffePharm didn’t just exhibit, it demonstrated why it’s a leader in science-backed healthy aging and precision nutrition. But the brand’s vision extends beyond anti-aging: Leveraging LipoAvail®, EffePharm also unveiled expansions into Asia’s hottest wellness trends, including beauty-from-within (liposomal glutathione) and liver health (liposomal silymarin/curcumin), solidifying its role as a dynamic liposome manufacturer poised for diverse growth. Industry Frenzy: EffePharm Under the Spotlight at "Healthy Aging" Hub This year, “healthy aging” wasn’t just a buzzword at Vitafoods Asia; it was the defining theme, and EffePharm was its unmissable star. The brand’s booth became a must-visit stop on Nutri Marketing’s curated “Age-Specific Nutrition Tour,” drawing throngs of formulators, brand owners, and researchers eager to explore solutions for aging populations. Even…

EffePharm, a global NAD+ manufacturer and liposomal pioneer, will showcase UTHEVER® NMN, UthPeak® NMNH, and LipoAvail® technology at Vitafoods Asia 2025 in Bangkok, Sept 17–19.

Discover EffePharm's latest liposomal and anti-aging innovations, including LipoAvail™, UTHEVER®, and more—enhancing health through science and efficacy.

Discover EffePharm’s cutting-edge active ingredients delivery solutions—the premium NAD+ manufacturer, bulk NMN supplier, and liposomal supplement technology leader. Meet us at HNC Expo (June 24-26) to explore UTHEVER® NMN, UthPeak® NMNH & LipoAvail™’s bioavailability breakthroughs.

May 20–22, 2025, EffePharm, a global leader in healthy aging and nutritional biotechnology, captivated attendees at Vitafoods Europe 2025 in Barcelona. Showcasing groundbreaking advancements in NAD+ research and nutrient delivery systems for improved dietary supplements, EffePharm solidified its position as a pioneer in scientifically validated anti-aging solutions. Here’s a deep dive into their latest breakthroughs and strategic vision. Revolutionizing NAD+ Supplementation EffePharm’s NAD+ Booster Series stole the spotlight, offering tangible solutions to age-related NAD+ supplementation—a key driver of cellular aging. What is NAD+? Read more UTHEVER® NMN: UTHEVER® NMN is the world's first clinically proven NMN brand. It is now positioned to become the first NMN ingredient to secure EU Novel Food certification. UTHEVER® is currently in the final review stage with the European Food Safety Authority (EFSA). Its impending approval paves the way for EU market entry, with multiple brands already securing pre-orders to capitalize on this regulatory milestone. Learn more about the NMN Novel Food Updates. UthPeak® NMNH (Reduced NMN): Backed by the world’s first double-blind human trial, UthPeak® demonstrated a 3x increase in NAD+ levels and a maximum 5-year reversal in biological age after 90 days of supplementation. Being EffePharm's premium NAD+ enhancer, its safety has already…

Join Effepharm at Booth 3G84 during Vitafoods Europe 2025 (May 20–22, Barcelona) to explore groundbreaking solutions that redefine healthy aging and nutrition absorption. Our team is eager to connect and share how our science-driven innovations can elevate your formulations and empower global wellness. Spotlight on Science: NAD Booster Line UthPeak® NMNH: The only Self-GRAS-approved NMNH with proven anti-aging results in 90 days. Longevity: Reverse biological age markers by up to 5 years* Energy & Mood: 35% boost in energy and 31% uplift in emotional well-being* NAD level increase: Up to 3X increase in NAD+ level* *Clinically validated in UthPeak® NMNH human trials (world's first clinical trial on reduced NMN). Learn More about the clinical study results. UTHEVER® NMN: Leading the EU Novel Food race—first to reach EFSA’s final review stage (approval expected 2025). Read more. Meet More Innovations with LipoAvail™ liposomal technology Explore Effepharm’s full portfolio in nutrition with unmatched absorption, including: LipoAvail™ Iron: 10mg/mL liquid concentration (5–10x industry standard) with 4x better absorption. LipoAvail™ Glutathione: 13x higher antioxidant delivery, bypassing stomach acid. LipoAvail™ Vitamin C: 7.86x enhanced uptake for immune and skin support. More at Effepharm’s Booth? Expert Insights: Engage with Dr. Yu Jianjun (R&D Director) and Dr. Rubén…

At SupplySide West 2024 in Las Vegas, the EffePharm team presented its groundbreaking LipoAvail™ liposome technology and innovative products designed to improve nutrient absorption and efficacy. These innovations underscore EffePharm’s commitment to advancing health solutions that address common challenges in the dietary supplement industry, with a particular focus on anti-aging and wellness. LipoAvail™ Liposomal Technology: Advancing Nutrient Delivery LipoAvail™ liposome technology is designed to overcome the widespread challenges in nutrient delivery. Active ingredients often face stability issues and poor absorption rates. This technology ensures better stability and improved bioavailability by encapsulating nutrients within protective lipid layers. For instance, NAD+—a crucial coenzyme for energy production and anti-aging—has traditionally been difficult to absorb effectively. LipoAvail™ technology improves its absorption by up to ninefold in the liver. Additionally, glutathione, an important antioxidant, benefits from an absorption boost of up to 13 times, enhancing its ability to support detoxification and cellular defense mechanisms. UthPeak™ NMNH: The Next-Generation NAD+ Enhancer One of EffePharm's key innovations is UthPeak™ NMNH. UthPeak™ NMNH is a form of reduced NMN (Nicotinamide Mononucleotide), serving as a direct precursor to NAD+, a crucial coenzyme for cellular energy production and longevity. This advanced formula has been shown to boost NAD+ levels by…

Your Product Innovation Begins Here! SupplySide West is around the corner, and we're thrilled to give you a peek at our showcase: 📌 UthPeak™ NMNH: World’s first self-GRAS approved NMNH (reduced NMN) 📌 LipoAvail™ Liposomal Technology: Science-validated liposomal technology to increase bioavailability. Visit 📍 booth 4055 to discover how we can elevate your product offerings. Schedule a meeting with our team and be part of the innovation wave!

SHANGHAI, China—EffePharm, the trailblazing biotech company, takes a moment to appreciate the incredible journey experienced at SupplySide West 2023, held at Mandalay Bay in Las Vegas. The event marked the introduction of UthPeak™, a captivating newcomer to the "Uth" series, EffePharm's esteemed flagship NAD+ booster line. The atmosphere at the EffePharm booth was nothing short of lively, with visitors and clients expressing genuine curiosity and enthusiasm for EffePharm's latest anti-aging innovations. UthPeak™, a patent-pending crystalline NMNH, emerged as a focal point, promising to be the next star in the realm of NAD+ boosters.  EffePharm is conducting research and development around the twelve hallmarks of aging, including UTHEVER® NMN, UTHEVER® Lipo liposomal NMN, ApiAge™ apigenin, and SuperMide™ Spermidine. The engaging discussions and shared excitement underscored EffePharm's commitment to creating wellness solutions grounded in clinical evidence.   Effe-IDS (Ingredient Delivery System), introduced during the event, offered a glimpse into the company's dedication to advancing active ingredient delivery. The system's use of innovative technologies such as LipoAvail™, EncapCirc™, and CelleSperse™ hinted at a future where bioavailability and functionality are seamlessly optimized.   SupplySide West 2023 served as a platform for EffePharm to connect with industry professionals and enthusiasts, fostering an atmosphere of collaboration…

EffePharm to Launch UthPeak™ at SupplySide West 2023 New member of the “Uth series” – EffePharm’s flagship NAD+ booster line SHANGHAI, China—Industry leading biotech company EffePharm will unveil its Next-Gen NAD+ Booster, UthPeak™, at booth #4965 during the SupplySide West 2023 from October 25 to 26 at Mandalay Bay in Las Vegas.   At booth #4965, EffePharm will showcase the “Uth series,” featuring groundbreaking anti-aging ingredients, including UthPeak™ NMNH, UTHEVER® NMN, and UTHEVER® Lipo liposomal NMN. Additionally, the frontier anti-aging ingredients range, which includes ApiAge™ apigenin and SuperMide™ Spermidine. Furthermore, the company will unveil the Effe-IDS, the advanced active ingredient delivery system utilizing LipoAvail™ liposomal technology, EncapCirc™ microencapsulation technology, and CelleSperse™ micelles technology.   SupplySide West 2023 is renowned for bringing together the brightest minds and top companies in the nutraceutical industry. EffePharm’s new initiative at SupplySide West 2023 aims to assist nutrition and health companies in developing user-friendly products with clinically-based concepts, and health solutions powered by advanced nutrient delivery methods to address the unmet health needs of individuals across all age groups.   UthPeak™: The Next-Gen Super NAD+ Enhancer UthPeak™ is a patent-pending crystalline NMNH, a reduced form of nicotinamide mononucleotide (NMN). “We firmly believe that UthPeak™ NMNH has the potential to become the…